Commonwealth Equity Services LLC reduced its stake in GE HealthCare Technologies Inc. by 34.4% in the third quarter, selling 91,088 shares and ending the period with 173,486 shares. This transaction trimmed Commonwealth’s exposure to the company by over $5 million at book value. Other notable moves include Mirae Asset Global Investments modestly increasing its position by 4.2%, Wedge Capital Management initiating a new holding valued at roughly $27 million, and National Bank of Canada FI more than doubling its stake to nearly 900,000 shares. In aggregate, institutional investors now control more than four-fifths of GE HealthCare’s outstanding equity, underscoring the importance of these portfolio adjustments for market sentiment.

In its most recent quarter, GE HealthCare delivered revenue of $5.14 billion, representing a year-on-year increase of 5.8%, and reported earnings per share of $1.07, beating consensus estimates by $0.02. The company’s net margin expanded to 10.94%, while return on equity stood at 22.52%. Management affirmed full-year guidance of 4.51–4.63 EPS, implying mid-single-digit growth in profitability and reflecting confidence in sustained demand for diagnostic imaging and lifecycle services offerings across developed and emerging markets.

GE HealthCare declared a quarterly dividend of $0.035 per share, marking an annualized payout of $0.14 and a yield of approximately 0.2%. With a payout ratio under 3%, the company retains substantial earnings for reinvestment in research, development and capacity expansion. Analysts remain broadly constructive: seven maintain buy or outperform ratings, while seven favor hold, resulting in a consensus view of Moderate Buy. Recent target revisions range from the mid-$80s to the mid-$90s, driven by expectations of continued margin expansion and strong capital returns.